UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549
                                  _____________

                                    Form 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (Date of earliest event reportedly): April 13, 2007


                              OCEAN BIO-CHEM, INC.
               (Exact name of registrant as specified in charter)

        Florida                            0-11102                59-1564329
    (State or Other              (Commission File Number)     (I.R.S. Employer
Jurisdiction of Incorporation)                               Identification No.)

               4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
                (Address of principal executive office Zip Code)

                                 (954) 587-6280
               Registrant's telephone number, including area code:

                                 Not Applicable
          (Former name or former address, if changes since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

     [ ] Written  communications  pursuant to Rule 425 under the  Securities Act
(17 CFR 230.425)

     [ ] Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

     [ ]  Pre-commencement  communications  pursuant to Rule 14d-2(b)  under the
Exchange Act (17 CFR 240.14d-2(b))

     [ ]  Pre-commencement  communications  pursuant to Rule 13e-4(c)  under the
Exchange Act (17 CFR 240.13e-4(c))




Item 5.02 - Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers


     (d) The Company's  Board of Directors,  pursuant to the  provisions  NASDAQ
Marketplace  Rule 4350(c )5,  appointed  Messrs.  Jeffrey S. Barocas,  Gregor M.
Dornau and  William W Dudman as new  members to the Board.  This  action will be
proposed for a shareholder  vote at the upcoming Annual Meeting of Shareholders.
A short biography of each new director is presented below:

     Jeffrey S. Barocas  joined the Company in December  2006.  He was appointed
Vice President - Finance and Chief  Financial  Officer on April 2, 2007. For the
five years immediately  preceding his employment he had held various  management
positions. He served as Chief Financial Officer of Quality Communications,  Inc.
and public companies, The Singing Machine, Inc. and Quipp, Inc.

     Gregor M. Dornau is the son of Peter G.  Dornau,  Ocean Bio Chem  President
and Chief Executive  Officer.  He has been employed by the Company as a salesman
since 1990 and during 2005 he was elected to serve as Vice President-Sales.

     William  W.  Dudman  joined  the  Company  in  February  2004  as our  Vice
President-Operations. For the five years immediately preceding his employment at
Ocean  Bio Chem he had held  various  management  positions  within  the  marine
industry, most recently with West Marine, Inc., our largest customer.





                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

April 16, 2007
                                          Ocean Bio-Chem, Inc.


                                          /s/ Peter G. Dornau
                                          -------------------------
                                          Peter G. Dornau
                                          Chairman of the Board and
                                          Chief Executive Officer